Abbott Begins Clinical Trial of Absorb Stent

Health care giant Abbott Labs (NYSE: ABT  ) has begun the ABSORB-III clinical trial of its drug-eluting bioresorbable stent, Absorb.

Absorb is the evolution of the modern stent in that it is made of completely dissolvable material, allowing it to absorb back into the bloodstream once its job is done.

The trial comes after Absorb's commercial release in Europe. Results from the ABSORB-III trial will be used in Abbott's filing for FDA approval for U.S. sales of the next-generation stent.

The ABSORB-III's primary endpoint involves testing lesion failure for safety and efficacy of the stent. Some patients will also be monitored for secondary endpoints, such as vasomotion -- how much a blood vessel regains natural motion after the dissolution of the Absorb stent.

Abbott Vascular's chief medical officer and division vice president of Medical Affairs spoke of the trial in a company press release, saying, "The advancement of Absorb into clinical trials in the United States represents an important step in the process of filing for U.S. regulatory approval -- with the goal of establishing Absorb as a new therapeutic option to treat U.S. patients with heart disease, the number one killer of men and women."

link


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2192086, ~/Articles/ArticleHandler.aspx, 10/22/2014 2:23:22 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement